{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:13:55Z","timestamp":1790046835011,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ejso.2025.110015","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T15:59:21Z","timestamp":1744041561000},"page":"110015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterization and clinical outcomes of rare biliary adenosquamous carcinoma"],"prefix":"10.1016","volume":"51","author":[{"given":"Anne","family":"Ruffat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Monnien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Fein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Doussot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucine","family":"Vuitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-7601","authenticated-orcid":false,"given":"Ang\u00e9lique","family":"Vienot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2025.110015_bib1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/1097-0142(19900315)65:6<1401::AID-CNCR2820650626>3.0.CO;2-K","article-title":"A clinicopathologic study of intrahepatic cholangiocarcinoma containing a component of squamous cell carcinoma","volume":"65","author":"Nakajima","year":"1990","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2025.110015_bib2","first-page":"622","article-title":"Extrahepatic bile duct cancer. Report of 106 cases","volume":"105","author":"Cao","year":"1992","journal-title":"Chin Med J (Engl)."},{"issue":"3","key":"10.1016\/j.ejso.2025.110015_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19970801)80:3<364::AID-CNCR3>3.0.CO;2-S","article-title":"Adenosquamous carcinoma of the liver: clinicopathologic characteristics and cytokeratin profile","volume":"80","author":"Maeda","year":"1997","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2009.07.012","article-title":"Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients","volume":"41","author":"Voong","year":"2010","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110015_bib5","first-page":"147","article-title":"Adenosquamous carcinoma of extrahepatic bile duct: clinicopathologic study of 12 cases","volume":"1","author":"Hong","year":"2008","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110015_bib6","first-page":"1069","article-title":"Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas","volume":"24","author":"Roa","year":"2011","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc."},{"issue":"6","key":"10.1016\/j.ejso.2025.110015_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jso.24065","article-title":"Squamous\/adenosquamous carcinoma of the gallbladder: analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma","volume":"112","author":"Song","year":"2015","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110015_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology."},{"issue":"5","key":"10.1016\/j.ejso.2025.110015_bib9","first-page":"443","article-title":"Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases","volume":"14","author":"Kardon","year":"2001","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc."},{"issue":"12","key":"10.1016\/j.ejso.2025.110015_bib10","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00535-003-1226-4","article-title":"Adenosquamous carcinoma of the pancreas: preoperative diagnosis and molecular alterations","volume":"38","author":"Murakami","year":"2003","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/01913128209016621","article-title":"Adenosquamous carcinoma of the pancreas: a light and electron microscopic study","volume":"3","author":"Kovi","year":"1982","journal-title":"Ultrastruct Pathol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110015_bib12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/SMJ.0b013e3181ebadbd","article-title":"Adenosquamous carcinoma of the pancreas: a distinct clinicopathologic entity","volume":"103","author":"Trikudanathan","year":"2010","journal-title":"South Med J"},{"issue":"11","key":"10.1016\/j.ejso.2025.110015_bib13","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.ccell.2023.09.008","article-title":"Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancer","volume":"41","author":"Rajbhandari","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ejso.2025.110015_bib14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00268-002-6585-0","article-title":"Adenosquamous carcinoma of the liver: clinicopathologic study of 10 surgically treated cases","volume":"27","author":"Yeh","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.ejso.2025.110015_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2147\/CMAR.S144850","article-title":"Adenosquamous carcinoma of the bile duct: a population-based study","volume":"10","author":"Qin","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ejso.2025.110015_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1116275","article-title":"Comparison of clinicopathological characteristics and long-term survival between patients with gallbladder adenosquamous carcinoma and pure gallbladder adenocarcinoma after curative-intent surgery: a single-center experience in China and a meta-analysis","volume":"13","author":"Lv","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110015_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/00365521.2016.1273383","article-title":"Adenosquamous carcinoma in the biliary tract: association of the proliferative ability of the squamous component with its proportion and tumor progression","volume":"52","author":"Hoshimoto","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejso.2025.110015_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.621594","article-title":"Treatment and survival patterns of primary adenosquamous carcinoma of the liver: a retrospective analysis","volume":"11","author":"Gou","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110015_bib19","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11605-020-04729-w","article-title":"Comparative outcomes of adenosquamous carcinoma of the gallbladder: an analysis of the national cancer database","volume":"25","author":"Murimwa","year":"2021","journal-title":"J Gastrointest Surg Off J Soc Surg Aliment Tract"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.21037\/jgo-22-1292","article-title":"Therapeutic response analysis for patients with adenosquamous carcinoma of the gallbladder: data analysis based on the Surveillance, Epidemiology, and End Results (SEER) database","volume":"14","author":"Fang","year":"2023","journal-title":"J Gastrointest Oncol"},{"issue":"14","key":"10.1016\/j.ejso.2025.110015_bib21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejso.2025.110015_bib22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","article-title":"Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial","volume":"22","author":"Lamarca","year":"2021","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2025.110015_bib23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1002\/ijc.34414","article-title":"Chemotherapy in advanced pancreatic adenosquamous carcinoma: a retrospective multicenter AGEO study","volume":"152","author":"Auvray Kuentz","year":"2023","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejso.2025.110015_bib24","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.21037\/jgo-22-434","article-title":"Chemotherapy is associated with improved survival in a national cohort of stage IV pancreatic adenosquamous carcinoma","volume":"13","author":"Altshuler","year":"2022","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2025.110015_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139748","article-title":"A nation-wide cancer registry-based study of adenosquamous carcinoma in taiwan. Lu SN","volume":"10","author":"Lan","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejso.2025.110015_bib26","doi-asserted-by":"crossref","first-page":"9926","DOI":"10.1002\/cam4.5700","article-title":"Pancreatic adenosquamous carcinoma: a population level analysis of epidemiological trends and prognosis","volume":"12","author":"Huang","year":"2023","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.ejso.2025.110015_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/(SICI)1097-0215(19980130)75:3<368::AID-IJC7>3.0.CO;2-0","article-title":"Rising incidence of biliary tract cancers in Shanghai, China","volume":"75","author":"Hsing","year":"1998","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2025.110015_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108498","article-title":"Sociodemographic trends in the incidence of pancreatic and biliary tract cancer in UK primary care","volume":"9","author":"Keane","year":"2014","journal-title":"PLoS One"},{"issue":"S1","key":"10.1016\/j.ejso.2025.110015_bib29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.ejso.2025.110015_bib30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/cncr.31942","article-title":"Biliary tract cancer incidence and trends in the United States by demographic group, 1999\u20102013","volume":"125","author":"Van Dyke","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2025.110015_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2010.06.039","article-title":"Trends in the incidence and management of biliary tract cancer: a French population-based study","volume":"54","author":"Lepage","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejso.2025.110015_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejca.2022.08.032","article-title":"Age trends in biliary tract cancer incidence by anatomical subtype: a Swedish cohort study","volume":"175","author":"Rahman","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2025.110015_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103892","article-title":"Rare histotypes of epithelial biliary tract tumors: a literature review","volume":"181","author":"Sapuppo","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ejso.2025.110015_bib34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(00)70435-4","article-title":"Triple-tissue sampling at ERCP in malignant biliary obstruction","volume":"51","author":"Jailwala","year":"2000","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.ejso.2025.110015_bib35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/gut.40.5.671","article-title":"A prospective evaluation of cytology from biliary strictures","volume":"40","author":"Mansfield","year":"1997","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib36","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/2303-9027.193597","article-title":"Endoscopic retrograde cholangiopancreatography versus endoscopic ultrasound for tissue diagnosis of malignant biliary stricture: systematic review and meta-analysis","volume":"7","author":"De Moura","year":"2018","journal-title":"Endosc Ultrasound"},{"issue":"8","key":"10.1016\/j.ejso.2025.110015_bib37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-2004-825657","article-title":"Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions","volume":"36","author":"Byrne","year":"2004","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.ejso.2025.110015_bib38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1542-3565(04)00005-9","article-title":"Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma","volume":"2","author":"Eloubeidi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110015_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cncr.11855","article-title":"Adenosquamous carcinoma of the pancreas: cytologic features in 14 cases","volume":"99","author":"Rahemtullah","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-022-00732-2","article-title":"Research advances and treatment perspectives of pancreatic adenosquamous carcinoma","volume":"46","author":"Zhang","year":"2023","journal-title":"Cell Oncol Dordr Neth"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00418-020-01864-y","article-title":"Cellular organization and histogenesis of adenosquamous carcinoma of the pancreas: evidence supporting the squamous metaplasia concept","volume":"154","author":"Boecker","year":"2020","journal-title":"Histochem Cell Biol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110015_bib42","first-page":"788","article-title":"Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: a preliminary report","volume":"17","author":"Hoshimoto","year":"2017","journal-title":"Pancreatol Off J Int Assoc Pancreatol IAP Al."},{"key":"10.1016\/j.ejso.2025.110015_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jss.2020.09.024","article-title":"Clinical and histological basis of adenosquamous carcinoma of the pancreas: a 30-year experience","volume":"259","author":"Moslim","year":"2021","journal-title":"J Surg Res"},{"issue":"7","key":"10.1016\/j.ejso.2025.110015_bib44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.5306\/wjco.v15.i7.936","article-title":"Rare primary squamous cell carcinoma of the intrahepatic bile duct: a case report and review of literature","volume":"15","author":"Ma","year":"2024","journal-title":"World J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/00015458.2013.11680879","article-title":"MUC1 and bcl-2 expression in preinvasive lesions and adenosquamous carcinoma of the lung","volume":"113","author":"Demirag","year":"2013","journal-title":"Acta Chir Belg"},{"issue":"3","key":"10.1016\/j.ejso.2025.110015_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/pin.12144","article-title":"MUC expression in adenosquamous carcinoma of the head and neck regions of J apanese patients: immunohistochemical analysis","volume":"64","author":"Kusafuka","year":"2014","journal-title":"Pathol Int"},{"key":"10.1016\/j.ejso.2025.110015_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/192458","article-title":"Mucoepidermoid carcinoma of the intrapancreatic common bile duct: immunohistochemical profile, prognosis, and review of the literature","volume":"2013","author":"Moul","year":"2013","journal-title":"Case Rep Pathol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110015_bib48","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s12105-020-01226-z","article-title":"Expression of mucins in salivary gland mucoepidermoid carcinoma","volume":"15","author":"Robinson","year":"2021","journal-title":"Head Neck Pathol"},{"issue":"10","key":"10.1016\/j.ejso.2025.110015_bib49","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/01.MP.0000028647.98725.8B","article-title":"The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis","volume":"15","author":"Adsay","year":"2002","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13000-015-0375-0","article-title":"CD109 is a novel marker for squamous cell\/adenosquamous carcinomas of the gallbladder","volume":"10","author":"Dong","year":"2015","journal-title":"Diagn Pathol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110015_bib51","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4251\/wjgo.v5.i7.159","article-title":"Pathological aspects of so called \u2018hilar cholangiocarcinoma\u2019","volume":"5","author":"Castellano-Meg\u00edas","year":"2013","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110015_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jss.2011.06.015","article-title":"415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival","volume":"174","author":"Boyd","year":"2012","journal-title":"J Surg Res"},{"issue":"6","key":"10.1016\/j.ejso.2025.110015_bib53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/MPA.0000000000001338","article-title":"Characteristics and outcomes of pancreatic cancer by histological subtypes","volume":"48","author":"Luo","year":"2019","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.ejso.2025.110015_bib54","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/cam4.2851","article-title":"The impact of squamous cell carcinoma histology on outcomes in nonmetastatic pancreatic cancer","volume":"9","author":"Gruhl","year":"2020","journal-title":"Cancer Med"},{"issue":"18","key":"10.1016\/j.ejso.2025.110015_bib55","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1200\/JCO.21.02568","article-title":"Long-Term outcomes and exploratory analyses of the randomized phase III BILCAP study","volume":"40","author":"Bridgewater","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2025.110015_bib56","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ejso.2025.110015_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.909257","article-title":"Survival analysis and prediction model of ASCP based on SEER database","volume":"12","author":"Lv","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110015_bib58","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/path.4959","article-title":"Recent advances in genomic profiling of adenosquamous carcinoma of the pancreas","volume":"243","author":"Marcus","year":"2017","journal-title":"J Pathol"},{"issue":"20","key":"10.1016\/j.ejso.2025.110015_bib59","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1158\/0008-5472.CAN-20-0078","article-title":"Genomic and epigenomic landscaping defines new therapeutic targets for adenosquamous carcinoma of the pancreas","volume":"80","author":"Lenkiewicz","year":"2020","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ejso.2025.110015_bib60","doi-asserted-by":"crossref","first-page":"768","DOI":"10.21037\/jgo-24-9","article-title":"PD-L1 expression in pancreaticobiliary adenosquamous carcinoma: a single-institution case series","volume":"15","author":"Ward","year":"2024","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110015_bib61","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.prp.2018.10.006","article-title":"PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component","volume":"214","author":"Tanigawa","year":"2018","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.ejso.2025.110015_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1456343","article-title":"Case report: microsatellite instability-high pancreas adenosquamous carcinoma with postoperative liver metastasis recurrence treated with multimodality therapy achieving complete pathological response","volume":"15","author":"Liu","year":"2024","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.ejso.2025.110015_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma - novel biological insights and therapeutic strategies","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.110015_bib64","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jamaoncol.2021.3836","article-title":"Final overall survival efficacy results of ivosidenib for patients with advanced cholangiocarcinoma with IDH1 mutation: the phase 3 randomized clinical ClarIDHy trial","volume":"7","author":"Zhu","year":"2021","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2025.110015_bib65","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","article-title":"Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study","volume":"21","author":"Abou-Alfa","year":"2020","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2025.110015_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2206834","article-title":"Futibatinib for FGFR2-rearranged intrahepatic cholangiocarcinoma","volume":"388","author":"Goyal","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejso.2025.110015_bib67","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1470-2045(23)00242-5","article-title":"Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study","volume":"24","author":"Harding","year":"2023","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325004433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325004433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:38:23Z","timestamp":1755495503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325004433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0748798325004433"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110015","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and clinical outcomes of rare biliary adenosquamous carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110015"}}